Mesa Laboratories, Inc. (MLAB)

Mesa Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net Income	-254.25	-254.25	0.93	1.87	3.27	1.78
Depreciation & Amortization	31.57	31.57	33.13	25.07	17.66	12.99
Share-Based Compensation	11.94	11.94	12.54	11.39	9.27	5.53
Other Operating Activities	254.87	254.87	-18.62	0.89	6.87	6.7
Operating Cash Flow	44.13	44.13	27.98	39.22	37.07	26.99
Operating Cash Flow Growth	57.71%	57.71%	-28.66%	5.80%	37.37%	-11.67%
Capital Expenditures	-2.57	-2.57	-4.54	-4.43	-1.99	-1.48
Acquisitions	-78.74	-78.74	-4.95	-300.79	0	-184.1
Investing Cash Flow	-81.31	-81.31	-9.49	-305.23	-1.99	-185.59
Dividends Paid	-3.45	-3.45	-3.41	-3.34	-3.17	-2.72
Share Issuance / Repurchase	0.36	0.36	7	8.03	150.88	89.94
Debt Issued / Paid	37.5	37.5	-36	49	-0.66	144.07
Other Financing Activities	-1.58	-1.58	-0.92	-1.11	-0.82	-0.01
Financing Cash Flow	32.84	32.84	-33.33	52.58	146.23	231.28
Exchange Rate Effect	-0.36	-0.36	-1.6	-1.09	1.18	-1.49
Net Cash Flow	-4.7	-4.7	-16.44	-214.52	182.49	71.2
Free Cash Flow	41.57	41.57	23.44	34.79	35.08	25.51
Free Cash Flow Growth	77.34%	77.34%	-32.63%	-0.83%	37.55%	-19.07%
Free Cash Flow Margin	19.23%	19.23%	10.70%	18.87%	26.19%	21.67%
Free Cash Flow Per Share	7.72	7.72	4.41	6.67	7.05	6.07

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).